KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Evolent Health (EVH) Accumulated Depreciation & Amortization (2016 - 2025)

Evolent Health (EVH) has 11 years of Accumulated Depreciation & Amortization data on record, last reported at $70.8 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization fell 20.5% year-over-year to $70.8 million; the TTM value through Sep 2025 reached $70.8 million, down 20.5%, while the annual FY2024 figure was $118.4 million, 4.09% down from the prior year.
  • Accumulated Depreciation & Amortization reached $70.8 million in Q3 2025 per EVH's latest filing, up from $47.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $123.4 million in Q4 2023 and bottomed at $15.1 million in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $55.6 million, with a median of $47.4 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 103.22% in 2023, then fell 20.5% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $60.0 million in 2021, then grew by 11.92% to $67.2 million in 2022, then soared by 83.67% to $123.4 million in 2023, then fell by 4.09% to $118.4 million in 2024, then crashed by 40.18% to $70.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $70.8 million in Q3 2025, $47.2 million in Q2 2025, and $24.1 million in Q1 2025.